Mast Group Ltd. has been a manufacturer of antibiotic susceptibility test products (AST)  for over 60 years and remains at the forefront of developments in this field. With a history of experience, quality and innovation, the expansion of the portfolio has resulted in the most comprehensive range available world-wide.

Mast Group Ltd. has a long history of collaborating with the Pharmaceutical industry, developing new AST products and offering a range of services, assuring confidence in the success of novel antimicrobial compounds on final commercialisation.

Mast Group Ltd. has an ever expanding range of AST products for the determination of bacterial and fungal antibiotic susceptibility in the treatment of infectious disease.

Products incorporate manual testing solutions including MASTDISCS^® AST,  MASTRING-S^® and Adatab^®s impregnated with antibiotics for susceptibility and MIC (minimum inhibitory concentration) testing by disc diffusion and multipoint technology in accordance with various national guidelines including The Clinical and Laboratory Standards Institute (CLSI) and The European Committee on Antimicrobial Susceptibility Testing (EUCAST).